PRME
Prime Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.70
−0.27%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+21.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 8, 2026 | Cahill Thomas · director | A-Award | 75,000 | $3.06 |
| Jun 8, 2026 | NELSEN ROBERT · director, 10 percent owner: | A-Award | 75,000 | $3.06 |
| Jun 8, 2026 | Kelly Michael Aaron · director | A-Award | 75,000 | $3.06 |
| Jun 8, 2026 | Foster-Cheek Kaye I · director | A-Award | 75,000 | $3.06 |
| Jun 8, 2026 | Chung Wendy · director | A-Award | 75,000 | $3.06 |
| Jun 8, 2026 | Schenkein David P · director | A-Award | 75,000 | $3.06 |
| Jun 8, 2026 | Marrazzo Jeffrey D · director | A-Award | 75,000 | $3.06 |
| Apr 17, 2026 | Makhni Svetlana Ni · officer: Chief Financial Officer | A-Award | 800,000 | $3.67 |
| Feb 27, 2026 | Reine Allan · director, officer: Chief Executive Officer | A-Award | 1,300,000 | $4.38 |
| Feb 24, 2026 | Alenson Carman · officer: See Remarks | A-Award | 140,000 | $3.34 |
| Feb 24, 2026 | LEE ANN L. · officer: Chief Technical Officer | A-Award | 375,000 | $3.34 |
| Aug 5, 2025 | Foster-Cheek Kaye I · director | A-Award | 9,006 | $4.04 |
| Aug 5, 2025 | Chung Wendy · director | A-Award | 45,000 | $4.04 |
| Aug 5, 2025 | Chung Wendy · director | A-Award | 39,062 | $4.04 |
| Aug 5, 2025 | Chung Wendy · director | A-Award | 13,510 | $4.04 |
| Aug 5, 2025 | Chung Wendy · director | A-Award | 9,006 | $4.04 |
| Aug 5, 2025 | Cahill Thomas · director | A-Award | 39,062 | $4.04 |
| Aug 5, 2025 | Reine Allan · director, officer: Chief Executive Officer | A-Award | 850,000 | $4.04 |
| Aug 5, 2025 | Alenson Carman · officer: See Remarks | A-Award | 90,498 | $4.04 |
| Aug 5, 2025 | Alenson Carman · officer: See Remarks | A-Award | 16,083 | $4.04 |
| Aug 5, 2025 | Alenson Carman · officer: See Remarks | A-Award | 6,254 | $4.04 |
| Aug 5, 2025 | GV 2021 GP, L.L.C. · 10 percent owner | Purchase | 1,500,000 | $3.30 |
| Aug 5, 2025 | Cahill Thomas · director | A-Award | 45,000 | $4.04 |
| Aug 5, 2025 | Marrazzo Jeffrey D · director | A-Award | 250,000 | $4.04 |
| Aug 5, 2025 | Marrazzo Jeffrey D · director | A-Award | 92,000 | $4.04 |
| Aug 5, 2025 | Marrazzo Jeffrey D · director | A-Award | 45,000 | $4.04 |
| Aug 5, 2025 | Kelly Michael Aaron · director | A-Award | 45,000 | $4.04 |
| Aug 5, 2025 | Kelly Michael Aaron · director | A-Award | 39,062 | $4.04 |
| Aug 5, 2025 | Kelly Michael Aaron · director | A-Award | 13,510 | $4.04 |
| Aug 5, 2025 | Kelly Michael Aaron · director | A-Award | 9,006 | $4.04 |
Institutional positioning
13F filings over the trailing two quarters
New 62Increased 140Reduced 119Sold out 25
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ALPHABET INC. | Unchanged | 16,562,498 | May 8, 2026 |
| Alphabet Inc. | Unchanged | 16,562,498 | Aug 7, 2026 |
| BlackRock, Inc. | Increased | 9,602,041 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 8,501,708 | May 13, 2026 |
| ARK Investment Management LLC | Increased | 8,348,746 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 7,576,460 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 6,345,125 | May 15, 2026 |
| ARK INVESTMENT MANAGEMENT LLC | Increased | 6,246,827 | May 12, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Reduced | 5,481,893 | May 15, 2026 |
| T. Rowe Price Investment Management, Inc. | Reduced | 5,237,332 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,522,640 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4,474,162 | May 15, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 4,123,365 | May 15, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Reduced | 3,969,082 | Aug 14, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 3,430,518 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 8, 2026